Jasper Therapeutics, Inc. (JSPR)Healthcare | Biotechnology | Redwood City, United States | NasdaqCM
0.61 USD
+0.03
(4.901%)
⇧
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:10 a.m. EDT
The investment case for Jasper Therapeutics has collapsed under the weight of its own history and current reality. The stock is a textbook value trap: despite trading at a fraction of its book value, the company has lost 96.58% of its value over the last five years, with the most recent annual drop being catastrophic at -82.49%. This is not a temporary correction; it is a structural implosion driven by deteriorating fundamentals, evidenced by massive negative free cash flow and a balance sheet that cannot sustain operations without external capital. The recent news of the company weighing options to sell assets or wind down confirms that the core business is no longer viable. While the analyst consensus suggests a target price nine times higher than the current level, such valuations are irrelevant for a biotech firm with no revenue and a path to profitability that appears blocked. The options market has spoken clearly, with heavy put buying acting as a hedge against total loss. There is no catalyst here to reverse the trend, and the risk of permanent capital loss remains extreme. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.216468 |
| MSTL | 0.345609 |
| AutoETS | 0.358219 |
| AutoARIMA | 0.379905 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 17.98 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.088 |
| Excess Kurtosis | -1.59 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 22.265 |
| Market Cap | 17,027,160 |
| Forward P/E | -0.24 |
| Beta | 3.07 |
| Previous Name | Amplitude Healthcare Acquisition Corporation |
| Website | https://jaspertx.com |
As of July 11, 2026, 3:10 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put open interest significantly exceeds call open interest across nearly all expirations, with deep out-of-the-money puts showing massive volume relative to calls. The implied volatility skew is inverted, with OTM puts trading at premiums while OTM calls are deeply discounted, indicating a market consensus that the probability of a further collapse outweighs any chance of a recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.832853 |
| Address1 | 2,200 Bridge Pkwy |
| Address2 | Suite 102 |
| All Time High | 188.8 |
| All Time Low | 0.315 |
| Ask | 0.767 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 2.4 - Buy |
| Average Daily Volume10 Day | 638,090 |
| Average Daily Volume3 Month | 501,054 |
| Average Volume | 501,054 |
| Average Volume10Days | 638,090 |
| Beta | 3.074 |
| Bid | 0.4705 |
| Bid Size | 2 |
| Board Risk | 10 |
| Book Value | 0.121 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.6079 |
| Current Ratio | 2.256 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.68 |
| Day Low | 0.58 |
| Debt To Equity | 22.265 |
| Display Name | Jasper Therapeutics |
| Earnings Timestamp | 1,778,788,800 |
| Earnings Timestamp End | 1,786,651,200 |
| Earnings Timestamp Start | 1,786,651,200 |
| Ebitda | -69,935,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.052 |
| Enterprise Value | 3,632,266 |
| Eps Current Year | -2.41 |
| Eps Forward | -2.56 |
| Eps Trailing Twelve Months | -2.71 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.66528 |
| Fifty Day Average Change | -0.05737996 |
| Fifty Day Average Change Percent | -0.086249344 |
| Fifty Two Week Change Percent | -83.2853 |
| Fifty Two Week High | 3.53 |
| Fifty Two Week High Change | -2.9221 |
| Fifty Two Week High Change Percent | -0.8277904 |
| Fifty Two Week Low | 0.315 |
| Fifty Two Week Low Change | 0.29290003 |
| Fifty Two Week Low Change Percent | 0.92984134 |
| Fifty Two Week Range | 0.315 - 3.53 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,578,666,600,000 |
| Float Shares | 23,583,680 |
| Forward Eps | -2.56 |
| Forward P E | -0.23746096 |
| Free Cashflow | -42,125,124 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 22 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0119 |
| Held Percent Institutions | 0.60607 |
| Implied Shares Outstanding | 28,009,802 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,704,326,400 |
| Last Split Factor | 1:10 |
| Long Business Summary | Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California. |
| Long Name | Jasper Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 17,027,160 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_647336542 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -55,734,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 16,231,680 |
| Number Of Analyst Opinions | 3 |
| Open | 0.6 |
| Operating Cashflow | -68,867,000 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 650 549 1400 |
| Prev Name | Amplitude Healthcare Acquisition Corporation |
| Previous Close | 0.5795 |
| Price Eps Current Year | -0.25224066 |
| Price Hint | 4 |
| Price To Book | 5.0239673 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.572 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.4 |
| Region | US |
| Regular Market Change | 0.0284 |
| Regular Market Change Percent | 4.90078 |
| Regular Market Day High | 0.68 |
| Regular Market Day Low | 0.58 |
| Regular Market Day Range | 0.58 - 0.68 |
| Regular Market Open | 0.6 |
| Regular Market Previous Close | 0.5795 |
| Regular Market Price | 0.6079 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 1,343,348 |
| Return On Assets | -1.1223 |
| Return On Equity | -2.44212 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 28,009,802 |
| Shares Percent Shares Out | 0.0608 |
| Shares Short | 1,703,161 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 2,246,874 |
| Short Name | Jasper Therapeutics, Inc. |
| Short Percent Of Float | 0.0622 |
| Short Ratio | 2.11 |
| Source Interval | 15 |
| State | CA |
| Symbol | JSPR |
| Target High Price | 20.0 |
| Target Low Price | 1.5 |
| Target Mean Price | 9.16667 |
| Target Median Price | 6.0 |
| Total Cash | 14,144,000 |
| Total Cash Per Share | 0.505 |
| Total Debt | 757,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.71 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.387385 |
| Two Hundred Day Average Change | -0.779485 |
| Two Hundred Day Average Change Percent | -0.56183755 |
| Type Disp | Equity |
| Volume | 1,343,348 |
| Website | https://jaspertx.com |
| Zip | 94,065 |